NeoGenomics Laboratories is a prominent provider of cancer genetics testing and information services, established in 2001 and based in Fort Myers, Florida. The company specializes in a comprehensive range of oncology-focused testing, which aids healthcare professionals in diagnosing and treating cancer effectively.
The services offered by NeoGenomics include advanced molecular and genetic testing for various cancers, support for clinical trials, and robust data management practices that prioritize patient data security. The company serves a diverse clientele, including pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, and managed care organizations. NeoGenomics operates multiple CAP accredited and CLIA certified laboratories across the United ...
NeoGenomics Laboratories is a prominent provider of cancer genetics testing and information services, established in 2001 and based in Fort Myers, Florida. The company specializes in a comprehensive range of oncology-focused testing, which aids healthcare professionals in diagnosing and treating cancer effectively.
The services offered by NeoGenomics include advanced molecular and genetic testing for various cancers, support for clinical trials, and robust data management practices that prioritize patient data security. The company serves a diverse clientele, including pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, and managed care organizations. NeoGenomics operates multiple CAP accredited and CLIA certified laboratories across the United States and has a full-service laboratory in the United Kingdom.
Over the years, NeoGenomics has expanded its capabilities through strategic acquisitions, enhancing its diagnostic and testing services to better support the healthcare community.
-
Number of Employees:
1K-5K
-
Annual Revenue:
$500M-1 Billion